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Introduction: Inflammatory mediators are key players in the pathogenesis of osteoarthritis 
(OA) and bone destruction. Conventional drugs suppress symptomatic activity and have no 
therapeutic influence on disease. Cissus quadrangularis and Withania somnifera are widely 
used for the treatment of bone fractures and wounds; however, the cellular and molecular 
mechanisms regulated by these herbals are still unclear.
Methods: We established an in vitro OA culture model by exposing human chondrocytes to 
proinflammatory cytokine and interleukin (IL)-1β for 36 hours prior to treatment with the herbals: 
C. quadrangularis, W. somnifera, and the combination of the two herbals. Cell viability, toxicity, and 
gene expression of OA modifying agents were examined. In addition, expression of survivin, which 
is crucial for cell growth, was analyzed. In vivo work on osteotomized rats studied the bone and 
cartilage regenerative effects of C. quadrangularis, W. somnifera, and the combination therapy.
Results: Exposure of chondrocytes to IL-1β induced significant toxicity and cell death. However, 
herbal treatment alleviated IL-1β induced cell toxicity and upregulated cell growth and prolifera-
tion. C. quadrangularis inhibited gene expression of cytokines and matrix metalloproteinases, 
known to aggravate cartilage and bone destruction, and augmented expression of survivin by 
inhibiting p38 MAPK. Interestingly, osteotomized rats treated with C. quadrangularis drasti-
cally enhanced alkaline phosphatase and cartilage tissue formation as compared to untreated, 
W. somnifera only, or the combination of both herbals.
Conclusion: Our findings demonstrate for the first time the signaling mechanisms regulated 
by C. quadrangularis and W. somnifera in OA and osteogenesis. We suggest that the chondro-
protective effects and regenerative ability of these herbals are via the upregulation of survivin 
that exerts inhibitory effects on the p38 MAPK signaling pathway. These findings thus validate 
C. quadrangularis as a potential therapeutic for rheumatic disorders.
Keywords: cytokines, inflammation, osteoarthritis, Withania somnifera, alternative therapy, 
herbal
Introduction
Osteoarthritis (OA) is a chronic disease directly associated to cartilage degeneration, 
joint inflammation, and bone sclerosis.1–3 Studies have shown significant superinduc-
tion of proinflammatory agents like interleukin-1β (IL-1β), tumor necrosis factor-α 
(TNF-α), and reactive oxygen species (ROS) during the osteoarthritic process. 
These mediators consequentially induce a destructive cascade of events that lead to 
a positive stimulatory loop of the cytokines as well as the synthesis of matrix metal-
loproteinase (MMP) and prostaglandins.4–6 Current therapeutics such as nonsteroidal 
correspondence: Jagat r Kanwar
nanomedicine-laboratory of immunology 
and Molecular Biomedical research 
(nliMBr), school of Medicine (soM), 
Molecular and Medical research (MMr) 
strategic research centre, Faculty 
of health, geelong Technology Precinct 
(gTP), Deakin University, Pigdons road, 
Waurn Ponds, Vic 3216, australia
Tel +61 3 52271148
Fax +61 3 52273402
email jagat.kanwar@deakin.edu.au 
Journal name: Drug Design, Development and Therapy
Article Designation: Original Research
Year: 2015
Volume: 9
Running head verso: Kanwar et al
Running head recto: Cissus quadrangularis induces chondroprotection and osteogenesis
DOI: http://dx.doi.org/10.2147/DDDT.S77369
 
D
ru
g 
De
sig
n,
 D
ev
el
op
m
en
t a
nd
 T
he
ra
py
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
20
2.
17
0.
57
.2
43
 o
n 
05
-D
ec
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Drug Design, Development and Therapy 2015:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2928
Kanwar et al
anti-inflammatory drugs and glucocorticoids offer symptom-
atic relief but disregard disease modification or progression. 
In addition, biologic treatments including TNF-α antagonist, 
etanercept (TNF inhibitor), and tanezumab (monoclonal 
antibody for β-nerve growth factors) enhance cartilage res-
toration, but their extended use induces severe side effects 
such as infections and gastrointestinal disorders.7 Therefore, 
long-term, nontoxic therapeutics for the treatment of chronic 
arthritis are imperative.
Studies worldwide have shown 60%–90% of arthritic 
patients are resolving to undertake complementary and 
alternative treatments as an alternative to conventional 
therapeutics.8 Herbals such as Cissus quadrangularis (Asthi 
Shrinkhala) and Withania somnifera (Ashwagandha) used 
for their bone healing and anti-inflammatory activities 
have recently been gaining worldwide recognition for their 
anti-arthritic effects. W. somnifera was reported to induce 
protective effects on mice with adjuvant-induced arthritis by 
significantly reducing urinary constituents, lipid peroxida-
tion, and glycoproteins and by increasing bone deposition.9 
In addition, immunomodulatory effects of W. somnifera 
reported by Rasool and Varalakshmi10 demonstrated sig-
nificant anti-inflammatory activity where W. somnifera 
drastically reduced complement activity, proliferation of 
lymphocytes, and inflammatory responses as a results of 
delayed-type hypersensitivity in arthritic mice as compared 
to control groups.10 The multifunctional herb C. quadran-
gularis was recently shown to induce proliferation, matrix 
mineralization, and differentiation of human osteoblastic 
cells.11 C. quadrangularis significantly relieved pain in 
patients suffering with OA by hindering the production of 
prostaglandins, the molecule associated with pain.12 These 
results demonstrate extensive therapeutic potentials of these 
herbals; however, more studies examining the molecular and 
cellular mechanisms remain to be elucidated.
Our lab has worked extensively with natural bioactive 
molecules as therapies for chronic diseases including cancer, 
brain disorders, and arthritis.13–18 Recently, we reported for 
the first time the therapeutic activity of the widely used herbal 
Lakshadi Guggul (LG) in collagen-induced arthritic mice.19 
In this study, LG significantly improved chondroprotectivity 
in cells exposed to inflammatory conditions and inhibited 
the production of prostaglandins and ROS. Furthermore, LG 
administered orally to collagen-induced arthritic mice signifi-
cantly lowered inflammation by inhibiting proinflammatory 
cytokines and induced cartilage regeneration.19 Although 
these herbal formulations have been used for many decades, 
the mechanisms by which they ameliorate anti-inflammatory 
and bone regenerative activities are vaguely understood. 
Therefore, by exploiting gene and protein expression of 
inflammatory markers, the molecular and cellular activity of 
C. quadrangularis and W. somnifera in chondrocytes were 
examined, and bone regenerative effects in osteotomized 
rats were elucidated.
Materials and methods
animal model
All animal procedures were approved by the Indian National 
Science Academy’s (INSA) Ethics committee and performed 
in accordance with the standards and guidelines for animal 
research set out by the academy in Ayurevedic College, 
Paprola, Kangra, Himachal Pradesh, India. Swiss Albino rats 
more than 3-months old of both sexes were used in this study. 
Animals were housed in a temperature controlled room under 
a 12-hour light/dark cycle. Rats had free access to a standard 
pellet diet and water. All animals were allowed to adapt to 
the new environment before the start of the experiment. 
To induce cartilage and bone damage, rats were first anes-
thetized with ketamine (60 mg/kg) and xylazine (8 mg/kg) 
and then osteotomized. The radial mid diaphyses of the 
left limb underwent open transverse osteotomy with a 
sharp osteotome. Rats were divided into four groups of six 
animals and each group was given either the control diet, 
C. quadrangularis, W. somnifera, or the combination of 
C. quadrangularis and W. somnifera at a dose of 0.018× 
human adult dose.20 Rats were fed treatment diets for 4 weeks 
before being euthanized according to INSA guidelines.
radiographic assessment of osteotomy
Following treatment with herbals, radiographic examinations 
of operated rat limbs from all four groups were analyzed. 
Craniocaudal and lateral views to evaluate the presence of 
bone callus were imaged. Radiographic changes were scaled 
from 0 to 5 depending on the severity of the osteotomy line 
observed (0= sharp or sclerotic line throughout; 1= in more 
than 75% of the diameter; 2= well-defined line extended 
in both projections; 3= extended only in one projection; 
4= osteotomy line seen faintly; 5= osteotomy not seen).
histopathological analysis of bone callus
Rat limbs subjected to osteotomy were dissected and fixed in 
10% formalin for 24 hours. Bones were decalcified in solution 
containing 10% sodium citrate and 14% EDTA for 5–7 days 
with gentle rocking. Following decalcification, tissues were 
dehydrated through a graded ethanol series and embedded 
in paraffin by routine procedures. Tissues were sectioned 
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into 10 µm slices and stained with hematoxylin and eosin. 
Tissue sections were evaluated and scored on a scale of 
1–11, in which 1= all fibrous tissue; 2= more fibrous tissue 
than cartilage; 3= fibrous and cartilaginous tissue in equal 
proportion; 4= fibrous tissue with more cartilaginous tissue 
than woven bone; 5= fibrous tissue with equal cartilage and 
woven bone; 6= fibrous tissue with more woven bone than 
cartilage; 7= cartilaginous tissue and woven bone in almost 
equal proportions; 8= less cartilage and more woven bone; 
9= entirely woven bone; 10= woven bone and some mature 
bone; and 11= lamellar (mature) bone.
alkaline phosphatase and histological 
assessment of bone structure
Four weeks postsurgery, rats were euthanized, and blood 
samples collected from heart and serum were used to analyze 
levels of alkaline phosphatase (ALP), following protocols as 
per manufacturer’s instructions.
Primary human Oa chondrocyte culture
Chondrocytes isolated from the cartilage in the knee joint of 
patients diagnosed with OA were purchased from Asterand, 
Detroit, MI, USA. Cells were cultured in Dulbecco’s Modified 
Eagle’s Medium/Ham’s F-12 media supplemented with 15% 
fetal bovine serum and 1% antibiotic–antimycotic. Cell pas-
sages between two and four were used for experiments. Prior 
to each assay, cells were plated at a density appropriate for 
the particular experiment and allowed to settle for 24 hours. 
Chondrocyte media was then replaced with media containing 
transforming growth factor-beta (TGF-β) (Lonza Group Ltd., 
Basel, Switzerland) to induce differentiation. Media were 
changed three times a week for approximately 10–12 days 
or until cells redifferentiated from fibroblastic morphology 
to a polygonal structure reported to be the structural char-
acteristics of chondrocyte cells.21 Following differentiation, 
chondrocytes were treated with 10 ng/mL of IL-1β (Biovision, 
Waterloo, NSW, Australia) for 36 hours before being treated 
with different concentrations of herbal extracts.
cell proliferation and cytotoxicity assay
Chondrocytes pretreated with IL-1β were treated for 
24 hours with increasing concentrations of C. quadrangularis 
and W. somnifera. Proliferation of cells by quantifying DNA 
replication (nuclear activity) was evaluated by CyQuant 
assay (Thermo Fisher Scientific, Waltham, MA, USA) 
which incorporates a fluorescence dye into dividing DNA. 
In order to evaluate the cytotoxicity induced by herbals, lactate 
dehydrogenase (LDH) cytotoxic detection kit (Hoffman-La 
Roche Ltd., Basel, Switzerland) was utilized. Briefly, cells 
pretreated with IL-1β and then incubated with herbal were 
briefly centrifuged at 800 rpm for 5 minutes. One hundred 
microliters of conditioned media was transferred to a 96-well 
plate and incubated with LDH reaction mixture for 30 minutes 
at room temperature (RT). Absorbance was read at 620 nm 
and percentage cell cytotoxicity was calculated relatively to 
IL-1β-only treated control.
Glycosaminoglycan production 
analysis
Glycosaminoglycans (GAGs) can be classified as the build-
ing blocks that make up the cartilage and help maintain 
its structure and integrity. During OA, reduced amount of 
GAG is reported in cartilage as compared to normal hyaline 
cartilage.22 Therefore, the production of GAG following treat-
ment with herbal extracts was examined using the Blyscan 
sulfated assay (Biocolor Ltd, Carrickfergus, UK). Briefly, 
IL-1β-exposed chondrocytes were treated with different con-
centration of herbal samples and incubated for 24 hours. One 
milliliter of Blyscan dye reagent (1,9-dimethyl-methylene 
blue) was mixed with 100 µL of conditioned media and 
incubated for 30 minutes with gentle shaking. The mixture 
was centrifuged and the supernatant discarded carefully. 
Five hundred microliters of dissociation reagent was added 
and concentration of GAG was quantified by measuring the 
absorbance at 656 nm.
Nitric oxide quantification
Total nitrite released from chondrocytes was measured using 
spectrophotometric methods utilizing the Griess reagent kit 
(Thermo Fisher Scientific). Supernatants from treated chon-
drocytes were mixed with the Griess reagent and incubated 
for 30 minutes at RT. Absorbance was measured at 540 nm 
and concentration calculated by comparing to a standard 
curve of NaNO
2
.
Quantitative real-time-polymerase 
chain reaction analysis
Cells preexposed to IL-1β were treated with herbal samples for 
24 hours, following which total RNA was isolated using TRI-
zol (Thermo Fisher Scientific) method. In addition, specific 
inhibitions of nuclear factor kappa B (NF-κB), (Bay 11-7082 
at 5 µM) and p38-mitogen-activated protein kinase (MAPK) 
(SB203580 at 50 µM) or vehicle (dimethyl sulfoxide; 0.1% 
v/v final concentration) were treated for 24 hours at 37°C 
and total RNA was isolated using the same method described 
above. Five micrograms of total RNA was reverse transcribed 
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with SuperScript III reverse-transcriptase (Thermo Fisher 
Scientific) and synthesized cDNA was amplified in duplicate 
with SYBR green master mix (Bio-Rad Laboratories Inc., 
Hercules, CA, USA). The following PCR protocol was used: 
60 cycles of 95°C for 30 seconds, annealing at 55°C for 
30 seconds, and 72°C for 40 seconds. Data was analyzed 
using 2-ΔΔCt method23 with actin as the reference gene. PCR 
products were electrophoresised on 1% agarose gels con-
taining SYBR safe DNA stain (Thermo Fisher Scientific, 
Waltham) and visualized under ultraviolet light.
Fluorescence-activated cell sorting 
analysis
Primary chondrocytes cultured in IL-1β for 36 hours were 
treated with 100 µg/mL of herbals. Following treatment, 
cells were washed briefly with 1X phosphate-buffered saline 
(PBS), fixed with 4% paraformaldehyde for 10 minutes at 
RT, and blocked for 30 minutes with 3% bovine serum albu-
min. Following blocking, cells were incubated with primary 
antibody purchased from Santa Cruz Biotechnology Inc. 
(Dallas, TX, USA) at a dilution of 1:100 and incubated for 
1 hour at RT. Cells were washed with PBS, centrifuged 
briefly, and resuspended in either anti-mouse–FITC (Sigma-
Aldrich Co., St Louis, MO, USA) or anti-goat–FITC (Sigma-
Aldrich Co.) at a 1:150 dilution for 1 hour in the dark. Cell 
were then analyzed using fluorescence-activated cell sorting 
to examine the expression of proteins.
Immunofluorescence for the expression 
of survivin
Expression of survivin in chondrocytes preexposed to IL-1β 
and then treated with herbals was analyzed using immuno-
fluorescence techniques. Briefly, following treatment, cells 
were washed with PBS, fixed with 4% paraformaldehyde 
for 20 minutes, and incubated with 0.2% Triton X-100 for 
10 minutes to permeabilize cells. Cells were then blocked 
with 3% horse serum for 1 hour at RT before being incubated 
for 1 hour with mouse-anti–survivin primary antibody (Santa 
Cruz Biotechnology Inc.). Cells were washed carefully and 
then incubated with anti-mouse secondary antibody labeled 
with tetramethylrhodamine (Sigma-Aldrich Co.) for 1 hour. 
Cells were washed carefully and mounted with DAPI mount-
ing media (Sigma-Aldrich Co.) before being imaged with 
confocal microscopy.
statistical analysis
Results from in vitro data are expressed as mean ± standard 
error of the mean from three independent experiments. 
P-values were evaluated by one-way analysis of variance 
with Tukey’s honestly significantly different post hoc tests. 
In vivo experimental data are presented as the mean ± 
standard error of the mean with the difference between groups 
assessed using Student’s t-test. P0.05 was considered sig-
nificant and P0.01 considered to be highly significant.
Results
herbal extracts enhanced chondrocyte 
proliferation
Undifferentiated chondrocytes that were fibroblastic in 
morphology (Figure 1A) were dedifferentiated with TFG-β 
until cells attained a spherical morphology (Figure 1B). 
Chondrocytes were then treated with IL-1β for 36 hours to 
activate osteoarthritic progressions. Initial experiments were 
to examine whether the herbal extracts, C. quadrangularis, 
W. somnifera, and the combination, had an effect on cell pro-
liferation and toxicity following IL-1β exposure. As shown 
in Figure 1C, cytotoxicity analyzed using LDH revealed a 
significant increase in toxicity of 21.2%±1.6% with IL-1β 
treatment; however, upon treatment with herbal samples, sig-
nificant reduction of IL-1β-induced toxicity were observed. 
With 50 µg/mL concentration, cytotoxicity was reduced by 
11.4%±0.5% with C. quadrangularis, 11.1%±0.85% with 
W. somnifera, and by 7.98%±0.98% with the combination 
as compared to IL-1β-only treatment. Proliferative effects 
induced by herbals demonstrated significant upregulation 
of cell growth in a dose-dependent manner (Figure 1D). 
IL-1β-only treated cells lowered growth by 10.9%±4.2% as 
compared to untreated cells; however, with herbals, IL-1β-
inhibited cell growth was diminished. Highest proliferation 
was observed at 200 µg/mL, with C. quadrangularis signifi-
cantly increasing cell viability by 34.4%±5.1% as compared 
to IL-1β-only treated cells.
C. quadrangularis induces 
chondroprotective activity
In order to examine the protective effects of herbal extracts, 
the regulation of nitric oxide (NO) and GAGs produced by 
chondrocytes was examined. As shown in Figure 2A, treat-
ment with IL-1β increased nitrite levels to 10.91±0.32 µM 
which was significantly reduced with increasing concentra-
tions of herbals. At 100 µg/mL, C. quadrangularis and the 
combination treatment reduced nitrite levels by 3.8-fold, 
whereas W. somnifera reduced nitrite levels by 1.9-fold 
relative to IL-1β-only treated cells. To further analyze the 
protective effects of herbals, the production of GAG by chon-
drocytes was examined (Figure 2B). Untreated chondrocytes 
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Figure 1 Morphological changes of chondrocytes and chondroprotective activity of herbals.
Notes: (A) Osteoarthritic chondrocytes grown in monolayer tend to attain a fibroblastic morphology. (B) incubation with culture media containing TgF-β for 10–12 days 
induce redifferentiation to chondrocytes confirmed by the spherical morphology. (C) lDh release was used to determine cytotoxicity effects induced by the herbal extracts 
and (D) cell viability analyzed using cyQUanT assay. Figure shows representative data of three independent experiments run in triplicate. Values correspond to means ± 
standard error; *P0.05. “-” means the il-1β was not added to the treatment whereas “+” denotes that il-1β was added before herbal treatment.
Abbreviations: c. quad, Cissus quadrangularis; il-1β, interleukin-1β; lDh, lactate dehydrogenase; TgF-β, transforming growth factor-β; W. som, Withania somnifera.
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Figure 2 regulation of nitric oxide and glycosaminoglycan production with herbal treatments.
Notes: il-1β pretreated chondrocytes were incubated with increasing concentrations of herbal sample for 24 hours. conditioned media was collected and measured for 
the production of nO (A) and gag (B). Figure shows representative data of two independent experiments run in triplicate and corresponds to means ± standard error; 
*P0.05; **P0.01. “-” means the il-1β was not added to the treatment whereas “+” denotes that il-1β was added before herbal treatment.
Abbreviations: c. quad, Cissus quadrangularis; gag, glycosaminoglycan; il-1β, interleukin-1β; nO, nitric oxide; W. som, Withania somnifera.
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produced GAG at levels of 16.90±0.13 µM; however, upon 
exposure to IL-1β, drastic reduction of GAG was observed 
with levels reducing to 11.16±0.23 µM. However, herbal 
treatment was found to induce a dose-dependent increase 
in GAG production. At 100 µg/mL, chondrocytes treated 
with C. quadrangularis expressed 18.15±1.48 µM of GAG, 
W. somnifera induced 16.74±0.23 µM production of GAG, 
and the combination significantly increased levels to 
20.04±0.01 µM as compared to IL-1β-only treated cells.
Downregulation of catabolic genes 
with C. quadrangularis and combination 
therapy
Human articular chondrocytes were stimulated with IL-1β 
(10 ng/mL) for 36 hours before treatment with the herbal 
extracts at a concentration of 100 µg/mL. As observed in 
Figure 3A and B, cells exposed to IL-1β alone showed an 
upregulation of gene expression of the catabolic factors, 
MMP-1, MMP-3, MMP-9, MMP-12, MMP-13, MMP-14, a 
disintegrin and metalloproteinase with thrombospondin motifs 
(ADAMTS)-5, nitric oxide synthase 2, and TNF-α. However, 
treatment with herbals significantly hindered expression of 
these catabolic factors. C. quadrangularis and combination 
therapy, at a concentrations of 100 µg/mL, downregulated 
gene expression of MMP-3, MMP-9, MMP-12, MMP-13, 
and prostaglandins 2 (PGE
2
). In addition, C. quadrangularis 
downregulated gene expression of MMP-15, IL-1β, 
IL-18, TNF-α, and PGE
2
. Treatment with W. somnifera 
downregulated IL-1β, TNF-α, and PGE
2
, however failed to 
show noteworthy regulation of MMPs and ADAMTs.
herbal extracts upregulated gene 
expression of anabolic factors 
and inhibited nF-κB
To overcome OA disease progression, production of cartilage 
regenerative molecules that assist cartilage resynthesis is 
critical. Gene expression of type II collagen and aggrecan, the 
building blocks of cartilage, was evaluated and was observed 
to significantly increase in levels upon treatment with herbal 
extracts (Figure 3C). W. somnifera significantly increased 
gene expression of type II collagen and aggrecan by tenfold 
and twofold, respectively, as compared to IL-1β-only treated 
cells. C. quadrangularis showed similar activity in which 
type II collagen and aggrecan were upregulated seven- and 
twofold, respectively. Survivin, a member of the inhibitor of 
apoptosis family, is associated with inhibition of cell apop-
tosis and promoting cell growth.24 Recent work has shown 
upregulation of survivin aids in chondrocyte proliferation and 
viability.13,19 As shown in Figure 3C, treatment with C. quad-
rangularis and W. somnifera induced survivin expression by 
fourfold and 2.5-fold, respectively, as compared to untreated 
(IL-1β-only) cells. Interestingly, inhibitory activity of herb-
als on inflammation-inducing pathways such as NF-κB 
and MAPK were also observed (Figure 3D). NF-κB was 
downregulated with all herbals and the combination treat-
ment reduced expression of extracellular signal-regulated 
kinases (ERK)2 and p38 MAPK signaling. No significant 
change, however, was observed with the JNK pathway. 
The involvement of NF-κB (Bay 11-7082 at 5 µM) and p38 
MAPK was further confirmed by using specific inhibitors 
(Figure 3E). There was a complete inhibition of these two 
important cell-signaling molecules confirming their roles in 
C. quadrangularis and W. somnifera treatments.
C. quadrangularis significantly induced 
cartilage regenerative proteins
Protein expressions of key osteoarthritic markers were 
examined via fluorescence-activated cell sorting analysis 
to evaluate the cartilage regenerative activity of C. quad-
rangularis. As shown in Figure 4, untreated chondrocytes 
expressed low levels of IL-1β (1.0%), MMP-3 (1.6%), 
and p38 MAPK (26.2%). However, as observed with gene 
expression, exposure to IL-1β significantly increased expres-
sion of these proteins by 96.2% (IL-1β), 86.3% (MMP-3), 
and 65.4% (p38 MAPK), respectively. Evidently, treat-
ment with C. quadrangularis and combination induced 
substantial protective effects on cells in which levels were 
drastically reduced by 64.4% (IL-1β), 11.1% (MMP-3), 
and 42.7% (p38 MAPK) with C. quadrangularis and 
54.9% (IL-1β), 35.8% (MMP-3), and 28.4% (p38 MAPK) 
with the combination therapy as compared to IL-1β only. 
W. somnifera was observed to show similar protective effects, 
however, to a much lesser potency compared to that of 
C. quadrangularis and the combination. To further demon-
strate the cartilage regenerative ability of herbals, expression 
of aggrecan was examined. As anticipated, IL-1β diminished 
levels of aggrecan; however, upon treatment with herbals, 
an increase of 35.9% with C. quadrangularis, 56.6% with 
W. somnifera, and 42.9% with the combination was observed 
as compared to IL-1β-only treated chondrocytes.
Upregulation of survivin with  
C. quadrangularis
Expression of survivin, as an indicator of antiapoptotic 
activity, was examined in IL-1β-exposed chondrocytes 
treated with herbals. As shown in Figure 5, survivin was 
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Figure 3 gene expression of cartilage-modifying agents in herbal-treated chondrocytes.
Notes: cells preexposed to il-1β were treated with 100 µg/ml of herbals extracts. gene expression of MMPs (A), inflammatory cytokines (B), anabolic agents (C), signaling 
pathways (D), and the activity of inhibitors on signaling pathways (E) were evaluated using quantitative real-time-polymerase chain reaction. Values correspond to means ± 
standard error from two independent experiments run in triplicate; *P0.05; **P0.01.
Abbreviations: aDaMTs, a disintegrin and metalloproteinase with thrombospondin motifs; c. quad, Cissus quadrangularis; cOX2, cyclooxygenase-2; DMsO, dimethyl 
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present in untreated chondrocytes and was localized in the 
cytoplasm and nucleus. However, upon exposure to IL-1β 
drastic reduction in survivin was observed and was predomi-
nantly present in the nuclei. Interestingly, C. quadrangularis 
and combination treatment reinstated levels of survivin to 
much higher levels than untreated cells, demonstrating the 
ability of herbals to inhibit IL-1β-induced cell toxicity and 
apoptosis.
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Nuclei
Untreated
(no IL-1β)
IL-1β only
Cissus
quadrangularis
Withania
somnifera
Cissus quadrangularis
+ Withania somnifera
Survivin Merge
91%±12.7%
23%±4.7%
89%±7.1%
19%±3.2%
93%±8.9%
Figure 5 Immunofluorescence analysis of survivin in chondrocytes.
Notes: OA chondrocytes were examined for the expression of survivin following treatment with herbals. Cells were stained with antigen-specific primary antibody followed 
by secondary antibody conjugated to tetramethylrhodamine dye. nuclei were counterstained with DaPi. cells were imaged using leica confocal microscopy and processed 
in Photoshop. representative images from two independent experiments are shown.
Abbreviations: il-1β, interleukin-1β; Oa, osteoarthritis.
C. quadrangularis and combination therapy 
stimulated cartilaginous tissue
The healing and regrowth capacity of herbals were evalu-
ated by examining stained bone sections of osteotomized 
rats treated with C. quadrangularis, W. somnifera, or 
combination of the two herbals. Histological scoring assessed 
for the formation of fibrous tissue, cartilaginous tissue, 
woven bone, and mature bone in bone calluses (Figure 6A). 
As compared to the control (untreated) group (Figure 6Aa) 
that showed high levels of fibrous tissue, rats treated with 
C. quadrangularis (Figure 6Ab) and combination (Figure 6Ad) 
showed enhanced levels of cartilaginous tissue and woven 
bone. W. somnifera therapy (Figure 6Ac), however, induced 
high levels of fibrous tissue, similar to what was observed in 
untreated rats, with increased woven bone tissue compared to 
cartilage. Figure 6Ae shows a histogram of the histopathologi-
cal scoring of rats following herbal treatments.
C. quadrangularis upregulated alP 
in surgically osteotomized rats
Levels of ALP were analyzed to evaluate whether herbal 
samples on osteotomized rats had an effect on bone 
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Figure 6 representative histopathological images of bone tissue and alP activity in rats that underwent osteotomy.
Notes: (A) (a) stained tissue sections of the control group, (b) Cissus quadrangularis-treated group, (c) Withania somnifera-treated group, and (d) combination group (original 
magnification ×10); (e) representative histopathological scores in osteotomized rats scaled from 0 to 11. representative images from bone sections are presented. (B) swiss 
albino rats surgically osteotomized and treated with herbal sample for 4 weeks were evaluated for levels of alP in serum. (C) The structural differences of the osteotomized 
area of the limb were evaluated through X-ray and the observed severity of bone callus scaled between 0 and 5. (D) representative radiographs showing the effects of 
different treatments; arrows indicate the area rats were osteotomized. Values correspond to means ± standard error (n=6 per group); *P0.05.
Abbreviations: alP, alkaline phosphatase; c. quad, Cissus quadrangularis; W. som, Withania somnifera.
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differentiation and proliferation. Serum samples collected 
from rats revealed increased levels of ALP with all herbal 
treatment as compared to rats fed on control diets (Figure 6B 
and C). Similar results were shown with different treatments 
(Figure 6D). C. quadrangularis induced a significantly high 
level of ALP at a concentration of 336.3±99.7 U/L; however, 
W. somnifera and combination showed no significant differ-
ence to the control group (168.3±48.0 U/L) with concentra-
tions increasing only by 45.3±46.1 U/L and 84.73±37.6 U/L, 
respectively. Furthermore, radiographic changes observed in 
osteotomized rats revealed no significant difference between 
herbal treated and control rats (Figure 6C). Osteotomy line 
was observed in rats given the combination herbal therapy; 
however, animals fed on C. quadrangularis showed faint 
osteotomy sclerosis.
Discussion
OA involves complex physiologies that lead to an imbalance 
of anabolic and catabolic factors present in the cartilage and 
surrounding bone.2 Key factors that promote degeneration 
involve proinflammatory mediators such as cytokines, prosta-
glandins, and oxidative species.6 Drugs like nonsteroidal anti-
inflammatory drugs and glucocorticoids are usually prescribed 
for chronic inflammatory and degenerative arthritis; however, 
their long term use leads to major discrepancies as effective 
therapeutics. Herbal therapies are recently gaining worldwide 
recognition by patients suffering from rheumatic disorders as 
alternative and complementary treatment strategies. Products 
such as gamma-linolenic acid from seed oils,25 curcumin,26 
and capsaicin27 have shown reduced joint swelling, pain, 
stiffness, and tenderness in patient with arthritis. However, 
it was also noted these treatments caused side effects such as 
gastrointestinal complications and burning sensations.
C. quadrangularis and W. somnifera are ayurvedic, natu-
ral compounds used widely for many decades. Popular for it 
antioxidant, anti-inflammatory, analgesic, and bone healing 
abilities, these herbals have proven to be beneficial in the 
treatment of inflammatory and rheumatic disorders. How-
ever, the mechanisms utilized by these compounds remains 
indistinct. Therefore, the present study was set to investigate 
the anti-inflammatory, cartilage-regenerative, and anti-
arthritic effects of C. quadrangularis and W. somnifera on an 
osteoarthritic in vitro model and in surgically osteotomized 
rats. It was demonstrated that all three herbals (C. quadran-
gularis, and W. somnifera, and the combination of both) were 
able to induce significant anti-inflammatory and chondro-
protective mechanisms on human chondrocytes preexposed 
to IL-1β cytokine. However, among the three samples, 
C. quadrangularis and the combination exhibited supreme 
inhibitory effects on disease progression. Augmented cell 
growth, inhibited ROS production, and diminished gene 
expression of catabolic factors were perceived, making them 
potential candidates for arthritis treatment.
IL-1β, a well-known proinflammatory cytokine, stimu-
lates the production of various other inflammatory cytokines 
along with cartilage degenerative agents such as MMPs and 
ROS. Their elevated levels stimulate production of PGE
2
, NO, 
MMP-1, MMP-3, MMP-9, MMP-12, and MMP-13 in osteoar-
thritic cartilage explants.28 Hence, utilizing IL-1β exposure 
as a mediator of OA progression, our in vitro model focused 
on the pretreatment of chondrocytes with IL-1β to initiate 
OA. Our results were similar to those of Yang et al28 in that, 
upon exposure of cells to IL-1β, upregulation of cytokines, 
MMPs, and ROS was observed. This validated the in vitro 
OA model as a practicable system to examine the therapeutic 
potentials of drugs for OA.
Chondrocyte viability and growth are vital features that 
are essential for the maintenance of cartilage structure and 
integrity. In this study, downregulation of proliferative activ-
ity and enhanced cytotoxicity in response to IL-1β treatment 
was evident. We demonstrated that incubation of chondro-
cytes with herbals significantly improved cell viability and 
proliferation and inhibited IL-1β-induced toxic effects on 
cells. C. quadrangularis showed higher proliferative activ-
ity as compared to untreated; however, the combination 
therapy, along with inducing cell proliferation, inhibited NO 
production and stimulated GAG synthesis. This enhanced 
therapeutic activity of the combination therapy may be 
associated to the synergistic chondroprotective effects of 
both herbals. Recently, work by Gupta and Singh reported 
the anti-inflammatory effects of W. somnifera in rats induced 
with collagen-induced arthritis.29 It was shown that oral treat-
ment of W. somnifera significantly reduced joint swelling 
and improved motor activity in arthritic rats as compared to 
untreated and methotrexate treated rats. It was suggested that 
the protective effects induced by W. somnifera may be due 
to its antioxidant, anti-inflammatory, and immunomodula-
tory activity.9,10,29 Similarly, studies with C. quadrangularis 
have shown enhanced bone healing and nontoxic effects in 
in vitro and in vivo models. It was reported to stimulate bone 
matrix mineralization, calcium deposition, anti-inflammation, 
and antioxidant activity.11 In addition, proliferation activity 
observed by osteoblasts treated with C. quadrangularis was 
via the upregulation of the MAPK pathway.30
Downstream cellular responses such as proliferation, 
inflammation, and apoptosis as a result of MAPK activation 
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are strongly associated to various stimuli. Proinflammatory 
cytokines such as IL-1β, and TNF-α, NO, and cyclooxy-
genases play essential roles in the activation of p38 MAPK 
and c-Jun N-terminal kinases (JNK) pathways. This in turn 
leads to inflammation, further cytokine production, osteoclast 
differentiation, and chondrocyte apoptosis.31,32 On the other 
hand, growth factors, such as TGF-β and insulin-like growth 
factor (IGF) modulate chondrocyte proliferation via inhibi-
tion of p38 MAPK and upregulation of ERK signaling.33 Our 
study showed similar results where exposure of chondrocytes 
to IL-1β significantly increased expression of proinflamma-
tory cytokines, NO, and p38 MAPK. However, treatment of 
cells with herbals, in particularly C. quadrangularis and the 
combination therapy, considerably alleviated production of 
catabolic agents by inhibiting activation of p38 MAPK and 
ERK2 signaling. Hence, it can be suggested that C. quadran-
gularis and the combination therapy act as growth factors by 
synergistically inducing cellular protection against inflam-
matory responses.
Survivin, a member of the inhibitor of apoptosis family, 
is closely associated to the regulation of most cancers in 
which its high expression promotes tumor growth, chemo-
therapy drug resistance, and inflammation.24,34 Extensive 
work from our laboratory has shown the therapeutic poten-
tials of targeting highly expressed survivin in colon, breast, 
and neuronal cancers using dominant negative survivin and 
naturally derived milk proteins such as iron-saturated bovine 
lactoferrin.15,35,36 Alternatively, it was also reported that 
survivin upregulation in normal cells promotes protection 
from detrimental stimuli such as ROS and proinflammatory 
cytokines.37,38 In addition, increased levels of survivin in 
human chondrocytes was shown to induce cell proliferation 
and inhibit apoptosis.39 Our study demonstrates similar results 
in which proinflammatory cytokine IL-1β inhibits the produc-
tion of endogenous survivin in human chondrocytes that in 
turn leads to reduced cell viability and proliferation. However, 
upon treatment with C. quadrangularis and W. somnifera, a 
significant increase in endogenous survivin was observed, 
thus stimulating cell growth. These reports further validate the 
signaling pathways activated by the herbals wherein treatment 
of cytokine-stressed chondrocytes with C. quadrangularis 
suppress p38 MAPK signaling via the activation of survivin 
(Figure 7).
In this study, Swiss albino rats were osteotomized 
surgically and used as an animal model to study the healing 
effects of the herbal extracts. This model of bone desta-
bilizing effectively mimics the structural damage seen in 
humans that have bone fractures or who suffer from OA as 
it provides similar morphological changes and underlying 
disease mechanisms as observed in patients. Treatment of 
rats with C. quadrangularis, W. somnifera, or combination 
resulted in an increased production of ALP in serum. ALP 
is an enzyme elevated in serum due to rapid bone growth 
and mineralization. Produced by osteoblasts as a result of 
increased activity and together with other proteins, ALP 
assists with bone mineralization.40 Previous work with C. 
quadrangularis has shown increased ALP activity with 
different osteoblastic cells line.11,30,41 It was shown that C. 
quadrangularis and its components were able to increase 
production of ALP by inducing proliferation, differentiation, 
and growth of osteoblasts cells. Results from our study corre-
lated with these finding where it was shown that, as compared 
to the other treatments, C. quadrangularis increased levels 
of ALP in serum.
Radiographic and histopathology analysis in our study 
further revealed the healing activity of the herbal extracts. 
We found that with C. quadrangularis and combination, 
bone healing was significantly enhanced with rapid forma-
tion of woven bone and cartilaginous tissue within 4 weeks 
of treatment. The healing property of C. quadrangularis has 
been previously shown in various in vivo models in which 
its use helped rapid restoration of bone strength and induced 
denser mineralization.42,43 Similarly, C. quadrangularis and 
W. somnifera are known for their use in bone fractures and 
as a therapy for OA. Clinical study with these herbals on 
patients suffering with OA showed effective therapeutic 
benefits.44 Possible mechanisms for the heightened thera-
peutic activity observed by these herbals is suggested to 
be due to their interactions with the transcriptional factor 
Runx2,20 increased production of IGF,45 and through the 
regulation of the MAPK signaling pathways.30 Further, our 
study demonstrates for the first time the interaction of these 
herbals with collagenases, nitric oxides, prostaglandins, and 
apoptotic proteins.
Conclusion
Taken together, the results presented in this study confirm 
the anti-inflammatory and cartilage-regenerative properties 
of C. quadrangularis and its mode of action via the inhibi-
tion of MMP and ROS. In addition, we propose that survivin 
plays a vital role in chondroprotection and osteogenesis 
by inhibiting p38 MAPK signaling pathways (Figure 7). 
Therefore, understanding the mechanisms by which these 
herbals mediate signaling molecules could have significant 
benefits for personalized treatment options for arthritic and 
inflammatory diseases.
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Figure 7 schematic diagram illustrating the therapeutic activity of Cissus quadrangularis.
Notes: C. quadrangularis inhibits catabolic activity of il-1β-induced inflammation and cartilage damage. Reduction of proinflammatory cytokines and MMPs are regulated by 
treatment of C. quadrangularis.
Abbreviations: il-1β, interleukin-1β; MaPK, mitogen-activated protein kinase; MMPs, matrix metalloproteinases; nO, nitric oxide; nF-κB, nuclear factor kappa B.
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